Compare Baxter International Inc (BAX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Citius Pharmaceuticals Inc — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.27B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Baxter International Inc is far larger — about 713.1× Citius Pharmaceuticals Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| BAX | CTXR | |
|---|---|---|
Market Cap | $14.27B | $20.01M |
Sector | Health | Health |
52-Week High | $28.35 | $1.82 |
52-Week Low | $15.80 | $0.48 |
Enterprise Value | $21.79B | $16.23M |
Dividend Yield | 0.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
